復星醫藥(02196.HK):復宏漢霖為子公司提供不超1.1億元擔保
格隆匯6月2日丨復星醫藥(02196.HK)發佈公告,2020年6月2日,公司控股子公司復宏漢霖與浦發銀行簽署《最高額保證合同》,由復宏漢霖為其全資子公司漢霖製藥於2020年6月2日至2021年6月1日期間因融資與浦發銀行所發生的債務提供最高額連帶責任保證擔保,該等債務的本金不超過等值人民幣1,000萬元。
同日,復宏漢霖、漢霖製藥與招商銀行簽署《授信協議》,復宏漢霖(作為授信申請人)、漢霖製藥(作為授信共享申請人)共同向招商銀行申請本金總額不超過人民幣10,000萬元的共享授信額度,授信期間為2020年6月2日至2021年6月1日。同日,復宏漢霖簽發《最高額不可撤銷擔保書》,由復宏漢霖為漢霖製藥於上述共享授信額度項下債務提供最高額連帶責任保證擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.